STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)
Status:
Active, not recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether starting anastrozole prior to radiotherapy,
so that it is taken during radiotherapy, decreases local recurrence of breast cancer in
post-menopausal women in comparison to waiting until after radiotherapy to commence
anastrozole.
Phase:
Phase 3
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)